Modern Chinese Medicine Group Co (HKSE:01643) Cash-to-Debt : 3,963.44 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Modern Chinese Medicine Group Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Modern Chinese Medicine Group Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 3,963.44.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Modern Chinese Medicine Group Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Modern Chinese Medicine Group Co's Cash-to-Debt or its related term are showing as below:

HKSE:01643' s Cash-to-Debt Range Over the Past 10 Years
Min: 7.18 Med: 717.99 Max: No Debt
Current: 3963.44

During the past 7 years, Modern Chinese Medicine Group Co's highest Cash to Debt Ratio was No Debt. The lowest was 7.18. And the median was 717.99.

HKSE:01643's Cash-to-Debt is ranked better than
94.07% of 1046 companies
in the Drug Manufacturers industry
Industry Median: 0.92 vs HKSE:01643: 3963.44

Modern Chinese Medicine Group Co Cash-to-Debt Historical Data

The historical data trend for Modern Chinese Medicine Group Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Modern Chinese Medicine Group Co Cash-to-Debt Chart

Modern Chinese Medicine Group Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

7.18

13.22

429.52

717.99

3,963.44

Modern Chinese Medicine Group Co Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial						429.52	1,319.80	717.99	2,094.87	3,963.44

Competitive Comparison of Modern Chinese Medicine Group Co's Cash-to-Debt

For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Modern Chinese Medicine Group Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Modern Chinese Medicine Group Co's Cash-to-Debt falls into.

Modern Chinese Medicine Group Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Modern Chinese Medicine Group Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	313.112	/	(0.079	+	0)
	=	3,963.44

Modern Chinese Medicine Group Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	313.112	/	(0.079	+	0)
	=	3,963.44

Modern Chinese Medicine Group Co (HKSE:01643) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Modern Chinese Medicine Group Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Modern Chinese Medicine Group Co (HKSE:01643) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modern Chinese Medicine Group Co Ltd (HKSE:01643) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88 Jinwei Road, Hebei, Chengde, CHN, 068150

Website

http://www.cdysjdyy.com

Modern Chinese Medicine Group Co Ltd is engaged in the production of proprietary Chinese medicine. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, and Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxification Pill. The Group has one operating segment of its business as a whole as the production of PCM. Geographically, the majority is from PRC.

Executives

Sun Xinlei	2201 Interest of corporation controlled by you
Xian Dai Sheng Wu Ke Ji Ji Tuan Kong Gu You Xian Gong Si	2101 Beneficial owner
Xie Wei	2201 Interest of corporation controlled by you

Modern Chinese Medicine Group Co (HKSE:01643) Headlines

No Headlines